Prenatal diagnosis of CLCN4-related neurodevelopmental disorder in fetuses with congenital brain anomalies

Prenat Diagn. 2023 Aug;43(9):1247-1250. doi: 10.1002/pd.6404. Epub 2023 Jul 19.

Abstract

We report two male fetuses born to a healthy unrelated couple, with agenesis of the corpus callosum identified on detailed 20-week ultrasound scans and confirmed by in-utero MRI. Whole-genome sequencing identified a likely pathogenic missense variant in the CLCN4 gene, establishing this as the causative gene in the family. Pathogenic variants in the CLCN4 gene cause a neurodevelopmental disorder (also called Raynaud-Claes syndrome) inherited in an X-linked pattern. The disorder is characterised by developmental delay, intellectual disability, autism spectrum disorder, epilepsy, mental health conditions, and significant feeding difficulties, predominantly, but not exclusively, affecting males. This is the first report of a prenatal phenotype associated with variants in the CLCN4 gene. The diagnosis of the CLCN4-related neurodevelopmental disorder in this family allowed accurate genetic counseling and discussion of reproductive choices. This leaves uncertainty about the possibility of a postnatal neurodevelopmental phenotype in heterozygous females, which we discuss.

Publication types

  • Case Reports

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Chloride Channels
  • Corpus Callosum
  • Female
  • Fetus / pathology
  • Humans
  • Intellectual Disability* / genetics
  • Male
  • Nervous System Malformations*
  • Neurodevelopmental Disorders* / diagnostic imaging
  • Neurodevelopmental Disorders* / genetics
  • Pregnancy
  • Prenatal Diagnosis

Substances

  • CLCN4 protein, human
  • Chloride Channels